Further studies are needed to understand how the ACVR1/ALK2R206H activating mutation and BMP pathway signaling changes cardiac function, and how these conduction and structural changes affect medical care for patients with FOP. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.